Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial127

File Visits

Downloads
36218-371.pdf50

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial50

Number of downloads in the range

Downloads
36218-371.pdf20

Views

Views
November 202510
December 20253
January 202622
February 20260
March 20268
April 20264
May 20263
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • November 2025
    3
  • December 2025
    4
  • January 2026
    6
  • February 2026
    0
  • March 2026
    1
  • April 2026
    5
  • May 2026
    1
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States31
Brazil4
Algeria2
Peru2
Canada2
Argentina1
Colombia1
Finland1
United Kingdom1
Mexico1
 

Top countries by downloads

Downloads
United States10
Algeria1
Argentina1
 

Top cities views

Views
San Jose16
Ashburn1
Barquisimeto1
Batna City1
Belo Horizonte1
Caucete1
Cleveland1
Constantine1
Dakar1
Lake View1
 

Top cities by downloads

Downloads
Constantine1